| COVID-19 and the risk of relapse in multiple sclerosis patients: a fight with no bystander effect? M Etemadifar, N Sedaghat, A Aghababaee, PK Kargaran, MR Maracy, ... Multiple Sclerosis and Related Disorders 51, 102915, 2021 | 52 | 2021 |
| Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient M Etemadifar, AA Sigari, N Sedaghat, M Salari, H Nouri Human vaccines & immunotherapeutics 17 (10), 3481-3483, 2021 | 39 | 2021 |
| Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis M Etemadifar, H Nouri, M Pitzalis, ML Idda, M Salari, M Baratian, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (9), 986-994, 2022 | 31 | 2022 |
| Risk factors of severe COVID-19 in people with multiple sclerosis: A systematic review and meta-analysis M Etemadifar, H Nouri, MR Maracy, AA Sigari, M Salari, Y Blanco, ... Revue neurologique 178 (1-2), 121-128, 2022 | 28 | 2022 |
| SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: same story, different vaccine M Etemadifar, N Sedaghat, H Nouri, N Lotfi, A Chitsaz, R Khorvash, ... Multiple Sclerosis and Related Disorders 57, 103417, 2022 | 21 | 2022 |
| MRI signs of CNS demyelinating diseases M Etemadifar, H Ashourizadeh, H Nouri, PK Kargaran, M Salari, M Rayani, ... Multiple Sclerosis and Related Disorders 47, 102665, 2021 | 20 | 2021 |
| Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study M Etemadifar, AP Abhari, H Nouri, M Salari, S Maleki, A Amin, ... BMC neurology 22 (1), 64, 2022 | 18 | 2022 |
| Movement Disorders Associated with COVID-19 M Salari, B Zaker Harofteh, M Etemadifar, N Sedaghat, H Nouri Parkinson’s Disease 2021, 2021 | 17 | 2021 |
| Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis M Etemadifar, AP Abhari, H Nouri, AA Sigari, SM Piran Daliyeh, ... Human vaccines & immunotherapeutics 18 (1), 2041945, 2022 | 15 | 2022 |
| Conus medullaris involvement in demyelinating disorders of the CNS: a comparative study M Etemadifar, M Salari, PK Kargaran, AA Sigari, H Nouri, F Etemadifar, ... Multiple Sclerosis and Related Disorders 54, 103127, 2021 | 12 | 2021 |
| Acute macular neuroretinopathy and COVID-19 vaccination: Case report and literature review. S Fekri, M Khorshidifar, MS Dehghani, H Nouri, SH Abtahi Journal Francais D'ophtalmologie, S0181-5512 (22) 00403, 2022 | 11 | 2022 |
| Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an … M Etemadifar, H Nouri, M Salari, N Sedaghat Human vaccines & immunotherapeutics 18 (1), 2033540, 2022 | 11 | 2022 |
| Post-COVID-19 acute disseminated encephalomyelitis: case report and review of the literature M Etemadifar, AR Mansouri, H Nouri, N Sedaghat, M Salari, M Maghsoudi, ... Neuroimmunology Reports 2, 100066, 2022 | 11 | 2022 |
| Retinal ischemic cascade: new insights into the pathophysiology and imaging findings SH Abtahi, R Nourinia, M Mazloumi, H Nouri, JF Arevalo, H Ahmadieh Survey of ophthalmology 68 (3), 380-387, 2023 | 10 | 2023 |
| Frequency of diencephalic syndrome in NMOSD M Etemadifar, H Nouri, R Khorvash, M Salari, K Ghafari, A Aghababaee Acta Neurologica Belgica, 1-7, 2022 | 9 | 2022 |
| Smoking and environmental tobacco smoke exposure: implications in ocular disorders S Karimi, H Nouri, S Mahmoudinejad-Azar, SH Abtahi Cutaneous and ocular toxicology 42 (1), 1-7, 2023 | 7 | 2023 |
| The effect of fampridine on the risk of seizure in patients with multiple sclerosis M Etemadifar, M Saboori, A Chitsaz, H Nouri, M Salari, R Khorvash, ... Multiple Sclerosis and Related Disorders 43, 102188, 2020 | 6 | 2020 |
| Endogenous fungal endophthalmitis following COVID-19 hospitalization: evidence from a year-long observational study S Fekri, M Khorshidifar, F Esfahanian, A Veisi, H Nouri, SH Abtahi Journal Français d'Ophtalmologie 46 (5), 461-467, 2023 | 5 | 2023 |
| Eye disorders in the post-COVID era SH Abtahi, H Nouri, S Moradian, S Yazdani, H Ahmadieh Journal of Ophthalmic & Vision Research 16 (4), 527, 2021 | 5 | 2021 |
| Autoimmune encephalitis: the first observational study from Iran M Etemadifar, A Aghababaei, H Nouri, PK Kargaran, S Mohammadi, ... Neurological Sciences, 1-10, 2021 | 5 | 2021 |
Masoud EtemadifarIsfahan University of Medical Sciences在 med.mui.ac.ir 的电子邮件经过验证
